BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 12091407)

  • 1. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
    Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
    Philipp W; Speicher L; Humpel C
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
    Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
    Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages.
    Schroedl F; Brehmer A; Neuhuber WL; Kruse FE; May CA; Cursiefen C
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5222-9. PubMed ID: 18689706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and experimental research of corneal lymphangiogenesis after keratoplasty.
    Ling S; Lin H; Xiang D; Feng G; Zhang X
    Ophthalmologica; 2008; 222(5):308-16. PubMed ID: 18617753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
    Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
    Bono P; Wasenius VM; Heikkilä P; Lundin J; Jackson DG; Joensuu H
    Clin Cancer Res; 2004 Nov; 10(21):7144-9. PubMed ID: 15534085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
    Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
    Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
    Maruyama K; Nakazawa T; Cursiefen C; Maruyama Y; Van Rooijen N; D'Amore PA; Kinoshita S
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):3145-53. PubMed ID: 22511631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients.
    Geissler HJ; Dashkevich A; Fischer UM; Fries JW; Kuhn-Régnier F; Addicks K; Mehlhorn U; Bloch W
    Eur J Cardiothorac Surg; 2006 May; 29(5):767-71. PubMed ID: 16439147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LYVE-1-positive macrophages are present in normal murine eyes.
    Xu H; Chen M; Reid DM; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2162-71. PubMed ID: 17460275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High lymph vessel density and expression of lymphatic growth factors in peritoneal endometriosis.
    Reichelt U; Keichel S; Barcena de Arellano ML; Chiantera V; Schneider A; Mechsner S
    Reprod Sci; 2012 Aug; 19(8):876-82. PubMed ID: 22539358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions.
    Maruyama Y; Maruyama K; Kato Y; Kajiya K; Moritoh S; Yamamoto K; Matsumoto Y; Sawane M; Kerjaschki D; Nakazawa T; Kinoshita S
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4813-22. PubMed ID: 24985477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular mechanisms of lymphangiogenesis.
    Al-Rawi MA; Mansel RE; Jiang WG
    Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vessels identified in failed corneal transplants with neovascularisation.
    Diamond MA; Chan SWS; Zhou X; Glinka Y; Girard E; Yucel Y; Gupta N
    Br J Ophthalmol; 2019 Mar; 103(3):421-427. PubMed ID: 30348644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
    Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
    J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.